Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus

Journal of Neural Transmission

Volumn 117, Issue 10, 2010, Pages 1131-1137

  Fortunato, Jucélia J ^a   Réus, Gislaine Z ^a   Kirsch, Tamires R ^a   Stringari, Roberto B ^a   Fries, Gabriel R ^b   Kapczinski, Flávio ^b   Hallak, Jaime E ^c   Zuardi, Antônio W ^c   Crippa, José A ^c   Quevedo, João ^a,d  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d HOSPITAL SÃO JOSÉ   (Brazil)

Author keywords

Depression; Forced swimming test; Harmine; Imipramine; Monoamine oxidase

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; HARMINE; IMIPRAMINE; SODIUM CHLORIDE;

ANIMAL TISSUE; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; LONG TERM CARE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT;

ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; HARMINE; MALE; MONOAMINE OXIDASE INHIBITORS; RATS; RATS, WISTAR; UP-REGULATION;

EID: 78651250110     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-010-0451-2     Document Type: Article

References (50)

1. LC Assis GT Rezin CM Comim SS Valvassori JC Jereminas AI Zugno J Quevedo EL Streck 2009 Effect of acute administration of ketamine and imipramine on creatine kinase activity in the brain of rats Rev Bras Psiquiatr 31 247 252 10.1590/S1516-44462009000300010 19784492
2. O Berton EJ Nestler 2006 New approaches to antidepressant drug discovery: beyond monoamines Nat Rev Neurosci 7 137 151 1:CAS:528:DC%2BD28XlvV2qug%3D%3D 10.1038/nrn1846 16429123 (Pubitemid 43151600)
3. E Castrén 2005 Is mood chemistry? Nat Rev Neurosci 6 241 246 10.1038/nrn1629 15738959
4. E Castrén V Võikar T Rantamäki 2007 Role of neurotrophic factors in depression Curr Opin Pharmacol 7 18 21 10.1016/j.coph.2006.08.009 17049922 (Pubitemid 46238033)
5. B Chen D Dowlatshahi GM MacQueen J-F Wang LT Young 2001 Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication Biol Psych 50 260 265 1:CAS:528:DC%2BD3MXmtFSru7g%3D 10.1016/S0006-3223(01)01083-6 (Pubitemid 32778442)
6. G De Foubert SL Carney CS Robinson EJ Destexhe R Tomlinson CA Hicks TK Murray JP Gaillard C Deville V Xhenseval CE Thomas MJ O'Neill TS Zetterström 2004 Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment Neuroscience 128 597 604 10.1016/j.neuroscience.2004.06.054 15381288 (Pubitemid 39277429)
7. MJ Detke M Rickels I Lucki 1995 Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants Psychopharmacol 121 66 72 1:CAS:528:DyaK2MXos1WjsbY%3D 10.1007/BF02245592
8. VG Dias JS Aguni AK Bezzon 2004 Sindrome de Lyell por imipramina: relato de caso Arg Bras Oftalmol 67 943 955
9. R Duman 2004 Depression: a case of neuronal life and death? Biol Psychiatry 56 140 145 10.1016/j.biopsych.2004.02.033 15271581 (Pubitemid 38969145)
10. RS Duman LM Monteggia 2006 A neurotrophic model for stress-related mood disorders Biol Psychiatry 59 1116 1127 1:CAS:528:DC%2BD28XmtVOisbc%3D 10.1016/j.biopsych.2006.02.013 16631126
11. RS Duman GR Heninger EJ Nestler 1997 A molecular and cellular theory of depression Arch Gen Psychiatry 54 597 606 1:CAS:528:DyaK2sXltFCit7g%3D 9236543
12. Y Dwivedi JS Rao SR Hooriyah J Kotowski RR Conley RC Roberts, et al. 2003 Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects Arch Gen Psychiatry 60 273 282 1:CAS:528:DC%2BD3sXislKlsr4%3D 10.1001/archpsyc.60.3.273 12622660 (Pubitemid 36307438)
13. Farzin D, Mansouri N (2006) Antidepressant-like effect of harmane and other β-carbolines in the mouse forced swim test. Eur Neuropsychopharmacol 324:328-316
14. JJ Fortunato GZ Réus TR Kirsch RB Stringari L Stertz F Kapczinski JP Pinto JE Hallak AW Zuardi JA Crippa J Quevedo 2009 Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus Prog Neuropsychopharmacol Biol Psychiatry 13 1425 1430 10.1016/j.pnpbp.2009.07.021
15. JJ Fortunato GZ Réus TR Kirsch RB Stringari G Fries F Kapczinski JE Hallak AW Zuardi JA Crippa J Quevedo 2010 Effects of beta-carboline harmine on behavioural and physiological parameters observed in the chronic mild stress model: further evidence of antidepressant properties Brain Res Bull 81 491 496 1:CAS:528:DC%2BC3cXhtVGltLg%3D 10.1016/j.brainresbull.2009.09.008 19772900
16. BN Frey AC Andreazza KMM Ceresér MR Martins SS Valvassori GZ Réus J Quevedo F Kapczinski 2006 Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania Life Sci 79 281 286 1:CAS:528:DC%2BD28XltFyjsLk%3D 10.1016/j.lfs.2006.01.002 16460767 (Pubitemid 43782552)
17. LB Garcia CM Comim SS Valvassori GZ Réus LM Barbosa AC Andreazza L Stertz G Fries E Gavioli F Kapczinski J Quevedo 2008 Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus Prog Psychopharmacol Biol Psychiatry 32 140 144 1:CAS:528:DC%2BD1cXptlWrug%3D%3D 10.1016/j.pnpbp.2007.07. 027
18. LB Garcia CM Comim SS Valvassori GZ Réus LM Barbosa AC Andreazza L Stertz G Fries E Gavioli F Kapczinski J Quevedo 2008 Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels Bas Clin Pharmacol Toxicol 103 502 506 1:CAS:528:DC%2BD1cXhsFSnsbrN 10.1111/j.1742-7843.2008.00210. x
19. LSB Garcia CM Comim SS Valvassori GZ Réus L Stertz F Kapczinski EC Gavioli J Quevedo 2009 Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats Prog Psychopharmacol Biol Psychiatry 33 450 455 1:CAS:528:DC%2BD1MXjslKks7Y%3D 10.1016/j.pnpbp.2009.01.004
20. RA Glennon M Dukat B Grella S Hong L Costantino M Teitler C Smith C Egan K Davis MV Mattson 2000 Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5- HT(1A)), dopamine (D(2)) and benzodiazepine receptors Drug Alcohol Depend 60 121 132 1:CAS:528:DC%2BD3cXlsFCis70%3D 10.1016/S0376-8716(99)00148-9 10940539 (Pubitemid 30625015)
21. SL Gourley DD Kiraly JL Howell P Olausson JR Taylor 2008 Acute hippocampal brain-derived neurotrophic factor restores motivational and forced swim performance after corticosterone Biol Psychiatry 64 884 890 1:CAS:528:DC%2BD1cXht12gu7jJ 10.1016/j.biopsych.2008.06.016 18675955
22. EJ Huang LF Reichardt 2001 Neurotrophins: roles in neuronal development and function Annu Rev Neurosci 24 677 736 1:CAS:528:DC%2BD3MXls1ShsL4%3D 10.1146/annurev.neuro.24.1.677 11520916 (Pubitemid 32695243)
23. SM Husbands RA Glennon S Gorgerat R Gough R Tyacke J Crosby DJ Nutt JW Lewis AL Hudson 2001 Betacarboline binding to imidazoline receptors Drug Alcohol Depend 64 203 208 1:CAS:528:DC%2BD3MXmsFemurk%3D 10.1016/S0376-8716(01)00123-5 11543990 (Pubitemid 32816963)
24. F Karege G Perret G Bondolfi M Schwald G Bertschy JM Aubry 2002 Decreased serum brain-derived neurotrophic factor levels in major depressed patients Psychiatry Res 15 143 148 10.1016/S0165-1781(02)00005-7 (Pubitemid 34258493)
25. F Karege G Vaudan M Schwald N Perroud R La Harpe 2005 Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs Brain Res Mol Brain Res 136 29 37 1:CAS:528: DC%2BD2MXktVGls7c%3D 10.1016/j.molbrainres.2004.12.020 15893584 (Pubitemid 40704606)
26. H Kim SO Sablin RR Ramsay 1997 Inhibition of monoamine oxidase A by beta-carboline derivatives Arch Biochem Biophys 337 137 142 1:CAS:528: DyaK2sXktlGitg%3D%3D 10.1006/abbi.1996.9771 8990278 (Pubitemid 27198065)
27. ME Kozisek D Middlemas DB Bylund 2008 Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies Pharmacol Ther 117 30 51 1:CAS:528:DC%2BD2sXhsVSmtL3P 10.1016/j.pharmthera.2007.07.001 17949819 (Pubitemid 350192670)
28. V Krishnan EJ Nestler 2008 The molecular neurobiology of depression Nature 455 894 902 1:CAS:528:DC%2BD1cXht1GgurrE 10.1038/nature07455 18923511
29. MH Larsen A Hay-Schimidt LC Ronn JD Mikkelsen 2008 Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants Eur J Pharmacol 578 114 122 1:CAS:528:DC%2BD1cXhsFaitg%3D%3D 10.1016/j.ejphar.2007.08.050 17950272 (Pubitemid 350309578)
30. Li N, He X, Qi X, Zhang Y, He S (2010) The mood stabilizer lamotrigine produces antidepressant behavioral effects in rats: role of brain-derived neurotrophic factor. J Psychopharmacol (in press)
31. G Lucca CM Comim SS Valvassori GZ Réus F Vuolo F Petronilho EC Gavioli F Dal-Pizzol J Quevedo 2008 Increased oxidative stress in submitocondrial particles into the brain of rats submitted to the chronic mild stress paradigm J Psychiatr Res 43 864 869 10.1016/j.jpsychires.2008.11.002 19100996
32. G Lucca CM Comim SS Valvassori GZ Réus F Vuolo F Petronilho F Dal-Pizzol EC Gavioli J Quevedo 2009 Effects of chronic mild stress on the oxidative parameters in the rat brain Neurochem Int 54 358 362 1:CAS:528:DC%2BD1MXivVGltb4%3D 10.1016/j.neuint.2009.01.001 19171172
33. J Malberg AJ Eisch EJ Nestler RS Duman 2000 Chronic antidepressant treatment increases neurogenesis in adult hippocampus J Neurosci 20 9104 9110 1:CAS:528:DC%2BD3MXis1SqsA%3D%3D 11124987
34. L Marais DJ Stein WM Daniels 2009 Exercise increases BDNF levels in the striatum and decreases depressive-like behavior in chronically stressed rats Metab Brain Dis 24 587 597 1:CAS:528:DC%2BD1MXhsFSqtLrN 10.1007/s11011-009-9157- 2 19844781
35. C Mathers D Loncar 2006 Projections of global mortality, burden of disease from 2002 to 2030 PLoS Med 3 442 10.1371/journal.pmed.0030442 (Pubitemid 44875937)
36. R McArthur F Borsini 2006 Animal models of depression in drug discovery: a historical perspective Pharmacol Biochem Behav 84 436 452 1:CAS:528: DC%2BD28XptFCiu7Y%3D 10.1016/j.pbb.2006.06.005 16844210 (Pubitemid 44308553)
37. EJ Nestler M Barrot RJ DiLeone AJ Eisch SJ Gold LM Monteggia 2002 Neurobiology of depression Neuron 34 13 25 1:CAS:528:DC%2BD38XivVCjsrY%3D 10.1016/S0896-6273(02)00653-0 11931738 (Pubitemid 34270695)
38. M Nibuya EJ Nestler RS Duman 1996 Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus J Neurosci 16 2365 2372 1:CAS:528:DyaK28XhvVCksrw%3D 8601816
39. G Nowak M Schlegel-Zawadzka 1999 Alterations in serum and brain trace element levels after antidepressant treatment part I Zinc Biol Trace Elem Res 67 85 92 1:CAS:528:DyaK1MXhsFSmt7g%3D 10.1007/BF02784278 10065601
40. RD Porsolt M Le Pichon M Jalfre 1977 Animal model of depression Nature 266 730 732 1:CAS:528:DyaE2sXkvFGhur4%3D 10.1038/266730a0 559941
41. SH Preskorn B Baker S Kolluri FS Menniti M Krams JW Landen 2008 An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-Methyl-d-Aspartate antagonist, CP-101, 606, in patients with treatment-refractory major depressive disorder J Clin Psychopharmacol 28 631 637 1:CAS:528:DC%2BD1cXhtlyqu7zE 10.1097/JCP. 0b013e31818a6cea 19011431
42. G Racagni M Popoli 2010 The pharmacological properties of antidepressants Int Clin Psychopharmacol 25 117 131 10.1097/YIC.0b013e3283311acd 20305568
43. RC Shelton 2007 The molecular neurobiology of depression Psychiatr Clin North Am 30 1 11 10.1016/j.psc.2006.12.005 17362799 (Pubitemid 46386302)
44. Y Shirayama AC Chen S Nakagawa DS Russell RS Duman 2002 Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression J Neurosci 22 3251 3261 1:CAS:528:DC%2BD38XjtF2gtLw%3D 11943826
45. JA Siuciak DR Lewis SJ Wiegand RM Lindsay 1997 Antidepressant-like effect of brain-derived neurotrophic factor (BDNF) Pharmacol Biochem Behav 56 131 137 1:CAS:528:DyaK2sXisVGhtg%3D%3D 10.1016/S0091-3057(96)00169-4 8981620 (Pubitemid 27016116)
46. Y Song D Kesuma J Wang Y Deng J Duan JH Wang RZ Qi 2004 Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine Biochem Biophys Res Commun 317 128 132 1:CAS:528:DC%2BD2cXisVKmt74%3D 10.1016/j.bbrc.2004.03.019 15047157 (Pubitemid 38401973)
47. B Szewczyk E Poleszak M Sowa-Kuaema M Siwek D Dudek B Ryszewska-Pokraoeniewicz M Radziwoñ-Zaleska W Opoka J Czekaj A Pilc G Nowak 2008 Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action Pharmacol Rep 60 588 599 1:CAS:528:DC%2BD1MXisFCgt7k%3D 19066406
48. A Tamburella V Micale A Navarria F Drago 2009 Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats Prog Neuropsychoparmacol Biol Psychiatry 33 1205 1210 1:CAS:528:DC%2BD1MXhtV2qtr7N 10.1016/j.pnpbp.2009.07.001
49. Wang X, Yang Y, Zhou X, Wu J, Li J, Jiang X, Qu Q, Ou C, Liu L, Zhou S (2010) Propofol pretreatment increases antidepressant-like effects induced by acute administration of ketamine in rats receiving forced swimming test. Psychiatry Res (in press)
50. CA Zarate Jr JB Singh PJ Carson NE Brutshe R Ameli DA Luckenbaugh DS Charney HK Manji 2006 A randomized trial of an N-methyl-D-aspartate antagonist in treatment resistant major depression Arch Gen Psychiatry 63 856 864 1:CAS:528:DC%2BD28XovF2lsLo%3D 10.1001/archpsyc.63.8.856 16894061 (Pubitemid 44188478)